Roche will publish its Full Year Results of 2023 prior to the opening of the Swiss Stock Exchange on Thursday, 1 February 2024.

07:00 CET / 06:00 GMT / 01:00 AM EST / 10:00 PM PST (evening before)

Release will be e-mailed and posted on the Roche IR website

Presentation slides will be posted on the Roche IR website

14:00 - 16:00 CET / 13:00 - 15:00 GMT

08:00 - 10:00 AM EST / 05:00 - 07:00 AM PST

The webinar will start with presentations by senior management, followed by a Q&A session.

Presenters: Thomas Schinecker, CEO Roche Group

Teresa Graham, CEO Roche Pharmaceuticals

Matt Sause, CEO Roche Diagnostics

Alan Hippe, Chief Financial and IT Officer Roche

We would like to invite all interested parties to participate in the webinar and to pre-register for the event here.

Should you be unable to register for the webinar due to your company IT policy, please send an email to investor.relations@roche.com.

A replay of the webinar will be available via > ir.roche.com

Best regards, Bruno Eschli

Head of Investor Relations

Contact:

Dr. Bruno Eschli

Tel: +41 61 68-75284

Email: bruno.eschli@roche.com

Dr. Sabine Borngraber

Tel: +41 61 68-88027

Email: sabine.borngraeber@roche.com

(C) 2024 Electronic News Publishing, source ENP Newswire